美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Gastar Exploration

0.0561

0.0000

成交量：- -

成交額：- -

市值：1,228.22萬

市盈率：-0.13

高：0.0561

開：0.0561

低：0.0561

收：0.0561

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

廣生堂(300436.SZ)：GST-HG131聯合GST-HG141針對乙肝經治患者的臨牀試驗申請獲得受理

廣生堂(300436.SZ)：乙肝治療創新藥GST-HG131聯合GST-HG141的II期臨牀研究獲得優化審評審批試點項目確認書

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GST"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GST\",,,,,undefined,":{"symbol":"GST","market":"US","secType":"STK","nameCN":"Gastar Exploration","latestPrice":0.0561,"timestamp":1536249826821,"preClose":0.0561,"halted":4,"volume":0,"delay":0,"floatShares":69350000,"shares":218933504,"eps":-0.421675,"marketStatus":"退市","change":0,"latestTime":"05-13 16:54:46 EDT","open":0.0561,"high":0.0561,"low":0.0561,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.421675,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1747180800000},"marketStatusCode":4,"symbolChange":{"newSymbol":"GSTC","executeDate":"2018-09-07"},"adr":0,"adrRate":0,"listingDate":1136437200000,"exchange":"AMEX","adjPreClose":0.0561,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GST\",,,,,undefined,":{"symbol":"GST","floatShares":69350000,"roa":"--","roe":"--","lyrEps":-0.313395,"shares":218933504,"dividePrice":0,"high":0.0561,"amplitude":0,"preClose":0.0561,"low":0.0561,"week52Low":0.0561,"pbRate":"-0.13","week52High":1.39,"institutionHeld":0.3263,"latestPrice":0.0561,"eps":-0.421675,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.421675,"open":0.0561},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GST\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GST\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520540785","title":"廣生堂(300436.SZ)：GST-HG131聯合GST-HG141針對乙肝經治患者的臨牀試驗申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2520540785","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520540785?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 20:08","pubTimestamp":1742213297,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广生堂(300436.SZ)发布公告，公司创新药控股子公司福建广生中霖生物科技有限公司(简称“广生中霖”)于近日收到国家药品监督管理局下发的关于乙肝治疗创新药GST-HG131联合GST-HG141的临床试验申请《受理通知书》，拟针对核苷(酸)类似物NUC经治乙肝患者，挑战临床治愈乙肝。前述II期临床研究已于日前被纳入优化创新药临床试验审评审批试点项目，将有效缩短本次临床试验申请的审评审批周期。本次GST-HG131联合GST-HG141的II期临床试验申请获得受理，尚需进一步获得批准后才可开展临床研究，能否获得批准开展临床存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1262987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GST","03347","300436","BK1576","BK0239","BK1141","BK1583"],"gpt_icon":0},{"id":"2518221805","title":"廣生堂(300436.SZ)：乙肝治療創新藥GST-HG131聯合GST-HG141的II期臨牀研究獲得優化審評審批試點項目確認書","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221805","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518221805?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 21:05","pubTimestamp":1741611951,"startTime":"0","endTime":"0","summary":"2025年3月10日，福建广生堂药业股份有限公司创新药控股子公司福建广生中霖生物科技有限公司收到北京市药品监督管理局下发的《优化创新药临床试验审评审批试点项目确认书》，同意GST-HG131联合GST-HG141的II期临床研究纳入试点项目，将有效缩短临床审评审批周期。2025年1月，GST-HG131已按照II期临床方案要求完成了计划例数全部的患者入组。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10210548635518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK1574","159992","06978","BK1161","300436","GST"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GST\",params:#limit:5,,,undefined,":[{"date":"2018-09-07","symbol":"GST","newSymbol":"GSTC","type":"symbolChange","dateTimestamp":1536292800000},{"market":"US","date":"2018-08-09","symbol":"GST","fiscalQuarterEnding":"2018/06","expectedEps":-0.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2018-05-10","symbol":"GST","fiscalQuarterEnding":"2018/03","expectedEps":-0.04,"name":null,"time":"盤後","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2018-03-15","symbol":"GST","fiscalQuarterEnding":"2017/12","expectedEps":-0.03,"name":null,"time":"盤後","type":"earning","dateTimestamp":1521086400000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2017-11-08","symbol":"GST","fiscalQuarterEnding":"2017/09","expectedEps":-0.04,"name":null,"time":"盤後","type":"earning","dateTimestamp":1510117200000,"reportTimeType":"post","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GST\",market:\"US\",delay:false,,,undefined,":{}}}